Meta-Analysis of Predictors of All-Cause Mortality After Transcatheter Aortic Valve Implantation
The aim of this study was to identify predictors of 30-day and midterm mortality after transcatheter aortic valve implantation (TAVI)
When Should You Restart Anticoagulation in Patients Who Suffer an Intracranial Bleed Who Also Have a Prosthetic Valve
A best evidence topic in cardiac surgery was written according to the structured protocol. The question addressed was about the best time to restart anticoagulation in patients with intracranial bleed with a prosthetic valve in situ.
Should Eligibility for Heart Transplantation be a Requirement for Left Ventricular Assist Device Use? Recommendations Based on a Systematic Review
Left ventricular assist devices (LVADs) are used in chronic end-stage heart failure as "bridge to transplantation" (BTT) and, more recently, for transplant-ineligible patients as "destination therapy" (DT). We reviewed the evidence on clinical effects and cost-effectiveness of 2 types of continuous-flow LVADs (HeartMate II [HM II] and HeartWare), for BTT and DT patients.
Mechanical Ventilation in Acute Hypoxemic Respiratory Failure: A Review of New Strategies for the Practicing Hospitalist
This review focuses on emerging evidence regarding strategies for mechanical ventilation in patients with acute hypoxemic respiratory failure.
Pediatric Extracorporeal Life Support in Specialized Situations
The purpose of this review was to provide a systematic review of the literature regarding the use of extracorporeal life support (ECLS) in various specialized conditions, as part of the Pediatric Cardiac Intensive Care Society/Extracorporeal Life Support Organization Joint Statement on Mechanical Circulatory Support.
Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis Who are at High Risk for Surgical Complications: Summary Assessment of the California Technology Assessment Forum
The California Technology Assessment Forum is dedicated to assessment and public reporting of syntheses of available data on medical technologies. In this assessment, transcatheter aortic valve replacement (TAVR) was evaluated for patients with severe aortic stenosis (AS) who are at high risk for complications.